In 2022, the global contraceptives market is expected to be worth US$ 18 billion. Contraceptive drug and device demand is expected to grow at a 5.5 percent CAGR, with the total market size reaching US$ 30.8 billion by 2032. According to a recent study by Future Market Insights (FMI), devices will lead the market in terms of product, accounting for approximately 58.3 percent of the market in 2021.
By 2032, sales of contraceptive medications and devices are projected to reach US$ 30.8 billion, growing at a CAGR of 5.5% worldwide. W.H.O. works with partners at the international, regional, and national levels to strengthen and enhance family planning and reproductive health outcomes. In order to address the unmet need for family planning, these partnerships will streamline family planning programmes, increase access to contraceptive technologies and supplies, and mobilise international commitments.
Request Sample Copy of Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1091
It includes in-depth insights into the contraceptives market. Some of these are:
- The estimated value of the contraceptives market was at ~US$ 33,529 Mn in 2019. Through the course of the report’s forecast period, the market is exhibited to show a steady pace of growth.
- Regionally, North America dominates the contraceptives market globally.
- East Asia emerges as one of key markets owing to large population base, growing contraceptive awareness and initiatives taken by the respective country government.
- Female segment holds the most of the contraceptive market as compared to men.
- Key players are likely to focus on new product development in terms of drug & device, to stay relevant in developed markets.
Contraceptive Pills – the Most Lucrative Product Type
Contraceptive market contains drugs and devices. The devices market holds most the contraceptive market however drugs are anticipated to grow at highest CAGR owing to its beneficial property and easy consuming method. With the advancement of technology, the emergence of drugs have become popular as oral contraceptive pills which has the same purpose as other contraceptive drugs or devices. The simplicity and easy consumable method are expected to make it most popular contraceptive market. The other form of drugs such as topical and injectable contraceptives also witness strong market demand. Furthermore, these contraceptive pills are highly effective and does not interrupt in sex. Even in cases, it has been proved to reduce heavy and painful periods. All these factors and benefits are expected to fuel the sales of contraceptive drugs in the global market.
Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1091
Some of the leading players operating in the contraceptives market are Bayer AGPfizer Inc., Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Mylan N.V., Allergan Plc, Reckitt Benckiser Group plc, Veru Inc., Church & Dwight Co., Inc., Medisafe Distribution Inc., Cooper Surgical, Inc., Mayer Laboratories, Inc., Pfizer, The Female Health Company and others. As a result of increasing competition, companies are focusing on expanding their product portfolio with new innovation. In addition to this, mergers and acquisition remains a popular strategy among market players. Companies intend to expand their regional footprint through strategic collaborations.
- As a part of government’s initiative, the government of India had launched a new contraceptive pill named ‘Shukhi 3rd Generation’ in Nov 2019.
- In Spet. 2019, Exeltis USA, Inc. had announced the Launch of Slynd (drospirenone) tablets, the First and only progestin-only pill providing pregnancy prevention with a 24-hour missed pill window
Get Valuable Insights into Contraceptives Market
Future Market Insights, in its new report, presents an unbiased analysis of the global Contraceptives market, covering historical demand data and forecast figures for the period between 2019 and 2029. The study divulges compelling insights on the contraceptives market based on product type (contraceptive drugs – oral contraceptive pills, injectable, topical), gender (male, female), by price range (high range, low /economy), sales channel (Wholesaler/ Distributor, Hypermarket/ Supermarket, Specialty Stores, Drug & Pharma Stores, Convenience Stores, online, and others -hospitals, clinics etc.), region (North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa).
For more Report Customization, connect with us at @
https://www.futuremarketinsights.com/customization-available/rep-gb-1091
Market segmentation
Product Type
- Contraceptive Drugs
- Oral Contraceptive Pills
- Injectables
- Topical
- Contraceptive Devices
- Diaphgrams
- Sponges
- Vaginal Rings
- Subdermal Implants
- Intrauterine Device
- Condom
Gender
- Male
- Female
Price Range
- High Range
- Low / Economy Range
Sales Channel
- Wholesaler/ Distributor
- Hypermarket/ Supermarket
- Specialty Stores
- Drug & Pharma Stores
- Convenience Stores
- Online
- Others (hospitals, clinics etc.)
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
